Asahi Kasei Stock News

The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus ​sores in certain patients with weakened immune systems ‌who have not responded to available antiviral treatments.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices held a ceremony to celebrate the recognition of the 1983 commercialization of thin-film Hall elements as an IEEE Milestone.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics announced that the first patient has been dosed in a randomized Phase 2a clinical trial (NCT07503561) evaluating AIC468.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Therapeutics, Veloxis Pharmaceuticals, Calliditas Therapeutics, and AiCuris will come together under the Asahi Kasei Therapeutics brand.

GLENVIEW, Ill.--(BUSINESS WIRE)--Asahi Kasei Bioprocess will unveil the VANTIJ® SU-VFC Benchtop at Bioprocess International East (BPI EAST) 2026.

TOKYO--(BUSINESS WIRE)--Asahi Kasei Microdevices has announced that its CZ39 and CZ3K series have been adopted as in Microchip Technology's ML/AI-based AFD reference design.

TOKYO--(BUSINESS WIRE)--Asahi Kasei held a grand opening ceremony for its new Hipore™ wet-process lithium-ion battery separator coating line in Charlotte, North Carolina.

TOKYO--(BUSINESS WIRE)--Asahi Kasei(TOKYO:3407), a diversified global company, has developed a novel pre-doping technology for high-voltage lithium-ion batteries (LIBs) with silicon-based anodes. This technology enables lithium carbonate to serve as an additional lithium source at lower voltages, reducing the permanent capacity loss that typically occurs in silicon-rich cells during the first c...